Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Kartogenin may help treat hair loss by promoting hair growth and extending the hair growth phase.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

A molecule called α-ketobutyrate was found to extend lifespan and improve aging-related symptoms in worms and mice by activating certain cellular pathways and may help develop anti-aging treatments for humans.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

There may be a link between hair loss and heart disease in women, but more research is needed.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose can help treat hair loss by reducing certain hormones and promoting hair growth.